Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Immunity. 2024 Jul 9;57(7):1648-1664.e9. doi: 10.1016/j.immuni.2024.05.018. Epub 2024 Jun 13.
Allogeneic T cell expansion is the primary determinant of graft-versus-host disease (GVHD), and current dogma dictates that this is driven by histocompatibility antigen disparities between donor and recipient. This paradigm represents a closed genetic system within which donor T cells interact with peptide-major histocompatibility complexes (MHCs), though clonal interrogation remains challenging due to the sparseness of the T cell repertoire. We developed a Bayesian model using donor and recipient T cell receptor (TCR) frequencies in murine stem cell transplant systems to define limited common expansion of T cell clones across genetically identical donor-recipient pairs. A subset of donor CD4 T cell clonotypes differentially expanded in identical recipients and were microbiota dependent. Microbiota-specific T cells augmented GVHD lethality and could target microbial antigens presented by gastrointestinal epithelium during an alloreactive response. The microbiota serves as a source of cognate antigens that contribute to clonotypic T cell expansion and the induction of GVHD independent of donor-recipient genetics.
同种异体 T 细胞扩增是移植物抗宿主病 (GVHD) 的主要决定因素,目前的主流观点认为,这是由供体和受体之间组织相容性抗原差异驱动的。这种范例代表了一个封闭的遗传系统,其中供体 T 细胞与肽-主要组织相容性复合物 (MHC) 相互作用,尽管由于 T 细胞库的稀疏性,克隆询问仍然具有挑战性。我们使用小鼠干细胞移植系统中的供体和受体 T 细胞受体 (TCR) 频率开发了一个贝叶斯模型,以定义跨越遗传上相同的供体-受体对的 T 细胞克隆的有限共同扩增。供体 CD4 T 细胞克隆型的亚组在相同的受体中差异扩增,并依赖于微生物群。特定于微生物群的 T 细胞增强了 GVHD 的致死性,并可以靶向同种反应期间胃肠道上皮细胞呈递的微生物抗原。微生物群作为同源抗原的来源,有助于克隆型 T 细胞的扩增,并诱导与供体-受体遗传无关的 GVHD。
J Cell Mol Med. 2024-7
Cochrane Database Syst Rev. 2024-11-7
Blood Adv. 2025-7-8